Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.06. | Micro Systemation AB: Peter Gille appointed acting CEO of MSAB | 108 | GlobeNewswire (Europe) | The board of MSAB has appointed the current chairman, Peter Gille, as acting CEO with immediate effect. Peter Heuman is simultaneously leaving his position as CEO.
The work to recruit a permanent CEO... ► Artikel lesen | |
10.06. | Adventure Box Technology AB: Adventure Box Technology signs letter of intent for acquisition of Lion Gaming Group Inc. | 1.352 | GlobeNewswire (Europe) | Adventure Box Technologies AB ("Adventure Box") has entered into a Letter of Intent ("LOI") with Lion Gaming Group Inc. ("Lion"), a Canadian company specializing in gaming and betting services. Lion... ► Artikel lesen | |
10.06. | Sileon AB: David Larsson leaves his role as CEO for Sileon - Kent Hansson appointed acting CEO | 161 | GlobeNewswire (Europe) | Sileon AB's (publ) ("Sileon") Board of Directors has together with David Larsson agreed that he leaves his role as CEO that he has had since mid 2020. The Board has appointed Kent Hansson acting CEO... ► Artikel lesen | |
10.06. | Technip Energies and Mitsubishi Chemical announce licensing of improved OXO alcohol technology 'OXO M-Process' | 658 | GlobeNewswire (Europe) | Technip Energies (PARIS:TE) and Mitsubishi Chemical Corporation (Mitsubishi Chemical), a member of the Mitsubishi Chemical Group, announced that they are licensing an improved OXO alcohol technology... ► Artikel lesen | |
10.06. | SAS AB: Plan of reorganization in SAS AB's company reorganization announced | 136 | GlobeNewswire (Europe) | SAS AB (publ) (the "Company") announces the plan of reorganization in the Company's ongoing company reorganization proceeding (Sw. företagsrekonstruktion) in Sweden (the "Reorganization Plan"). The... ► Artikel lesen | |
10.06. | GENFIT S.A.: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis | 225 | GlobeNewswire (Europe) | Ipsen's Iqirvo® (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for Primary Biliary Cholangitis (PBC)First-ever drug developed in-house by GENFIT to... ► Artikel lesen | |
10.06. | Inception Growth Acquisition Limited Announces Extension of Business Combination Period and Additional Contribution to Trust Account to Extend Business Combination Period | 140 | GlobeNewswire (Europe) | New York, June 10, 2024 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited (NASDAQ: IGTA, the "Company"), a publicly traded special purpose acquisition company, announced today that at its annual... ► Artikel lesen | |
10.06. | Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to July 10, 2024 | 151 | GlobeNewswire (Europe) | Singapore, June 10, 2024 (GLOBE NEWSWIRE) -- Nova Vision Acquisition Corp. (NASDAQ: NOVV, the "Company"), a special purpose acquisition company, announced today that Nova Pulsar Holdings Limited,... ► Artikel lesen | |
10.06. | VS Media Holdings Limited Announces 1-for-7 Share Combination | 237 | GlobeNewswire (Europe) | HONG KONG, June 10, 2024 (GLOBE NEWSWIRE) -- VS Media Holdings Limited (NASDAQ: VSME, the "Company"), a leader in managing a global network of digital creators, today announced that it plans to implement... ► Artikel lesen | |
10.06. | Middlesex Water Company Names New Chief Financial Officer | 378 | GlobeNewswire (Europe) | ISELIN, N.J., June 10, 2024 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) has named Mohammed G. (Rally) Zerhouni as its new Senior Vice President, Chief Financial Officer and Treasurer... ► Artikel lesen | |
10.06. | Calavo Growers, Inc. Announces Second Quarter 2024 Financial Results | 221 | GlobeNewswire (Europe) | SANTA PAULA, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado industry leader and provider of convenient, ready-to-eat fresh food, today reported... ► Artikel lesen | |
10.06. | Syntec Optics (NASDAQ: OPTX) Announces Dean Rudy as New Chief Financial Officer | 148 | GlobeNewswire (Europe) | ROCHESTER, NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Syntec Optics ("Syntec" or the "Company") (Nasdaq: OPTX) named Dean Rudy Chief Financial Officer, effective June 10, 2024. Mr. Rudy succeeds... ► Artikel lesen | |
10.06. | byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination | 147 | GlobeNewswire (Europe) | New York, NY, June 10, 2024 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (NASDAQ: BYNO ("BYNO" or the "Company"), a special purpose acquisition company, announced today that the Company has... ► Artikel lesen | |
10.06. | Array Technologies, Inc.: Array Technologies Announces Departure of Chief Financial Officer | 242 | GlobeNewswire (Europe) | ALBUQUERQUE, N.M., June 10, 2024 (GLOBE NEWSWIRE) -- Array Technologies (NASDAQ: ARRY) ("Array" or the "Company"), a leading provider of tracker solutions and services for utility-scale solar energy... ► Artikel lesen | |
10.06. | TSS, Inc.: TSS Inc. (Total Site Solutions) Names Danny Chism as Chief Financial Officer | 153 | GlobeNewswire (Europe) | ROUND ROCK, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- Total Site Solutions (OTC:TSSI), a leader in end-to-end integration technology solutions for data centers and modular services, today announced... ► Artikel lesen | |
10.06. | Arcutis Biotherapeutics, Inc.: Arcutis Announces New Long-Term Data of Roflumilast Cream 0.15% for the Treatment of Mild to Moderate Atopic Dermatitis (AD) in Adults and Children Down to Age Six Presented at Revolutionizing Alopecia Areata, Vitiligo, and | 194 | GlobeNewswire (Europe) | Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment66.2% of participants treated with once-daily roflumilast... ► Artikel lesen | |
10.06. | Ipsen Pharma: Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | 611 | GlobeNewswire (Europe) | Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver... ► Artikel lesen | |
10.06. | Rajant Corporation: RAJANT AND EMBOTECH STRATEGIC PARTNERSHIP ADVANCES PORT AUTONOMY | 439 | GlobeNewswire (Europe) | Zurich Testing Validates Wireless Network Enablement of Fully Autonomous ApplicationsMalvern, Pennsylvania, the pioneer of Kinetic Mesh® wireless networks, and Embotech, a leading provider of autonomous... ► Artikel lesen | |
10.06. | London Research and Pharmaceuticals: London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid | 492 | GlobeNewswire (Europe) | LONDON, Ontario, June 10, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals presented notable pre-clinical data about its lead compound, LRP-661, also known as Cannabidiol Sulphate (CBDS),... ► Artikel lesen | |
10.06. | Cribl Accelerates Data Management Productivity with AI-Powered Copilot | 174 | GlobeNewswire (Europe) | Cribl Copilot turbocharges efficiency and bridges the skills gap, ushering in the next generation of AI-augmented workforce empowerment for IT and SecuritySAN FRANCISCO, June 10, 2024, the Data Engine... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.941 |
EVOTEC | 2.190 |
TUI | 1.876 |
BAYER | 1.809 |
NVIDIA | 1.697 |
NEL | 1.305 |
RENK GROUP | 1.160 |
RHEINMETALL | 1.058 |
TESLA | 886 |
PALANTIR TECHNOLOGIES | 839 |
DEUTSCHE BANK | 787 |
VOLKSWAGEN | 768 |
MICROSTRATEGY | 726 |
BYD | 708 |
PLUG POWER | 674 |
COMMERZBANK | 668 |
BASF | 645 |
JINKOSOLAR | 621 |
MERCEDES-BENZ | 603 |
AMAZON | 588 |
DEUTSCHE TELEKOM | 568 |
INTEL | 559 |
BMW | 557 |
ALLIANZ | 547 |
THYSSENKRUPP | 546 |